Home
NICE Guidance
Conditions and diseases
Cancer
Ovarian cancer
Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer
Technology appraisal guidance [TA285]
Published:
22 May 2013
Guidance
Tools and resources
Information for the public
Evidence
History
Do no do examples
Do no do examples for Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer
Title
Year published
Impact Level
No results could be found